Background

Since 1996, an urban community-based organisation whose primary mission is to serve diverse94 and emerging community health needs has provided screening, testing, overdose prevention and training, referrals, and access to treatment for substance use disorders (SUD) and communicable diseases such as HIV through its Life Points harm reduction program.

Methods

As a partner in a State survey in 2021, the community organisation recruited a convenience sample of people who use drugs to participate in a survey focused on their substance use, healthcare, and barriers to SUD services...

Background: Over the past decade, drug-related overdoses have seen a significant rise both in North America and globally. The COVID-19 pandemic has further emphasised the urgent need for safer supply programs to replace unregulated substances, reducing toxicity and overdose risks. Service providers play a crucial role in delivering safer supply initiatives, yet there's limited empirical evidence from their perspective on what constitutes effective safer supply programs. This study delves into the initial implementation and impacts of a safer supply program, capturing insights from an...

The Cannabis, Mental Health, and Substance Use Health: Research Knowledge Exchange Event Summary Report presents the findings and themes discussed at an event jointly hosted by CCSA (Canadian Centre on Substance Use and Addiction) and the Mental Health Commission of Canada. With funding from Health Canada, the two organizations supported approximately 70 research teams in exploring the potential benefits, harms, and risks of cannabis on substance use health and mental health. The event provided a platform for these research teams to share their project results, observations, and experiences...

Background

Lesbian, gay, bisexual, transgender, queer, and other LGBTQ populations (LGBTQ+; e.g., asexual individuals) have higher rates of substance use (SU) and disorders (SUD) compared to heterosexual and cisgender populations. Such disparities can be attributed to minority stress, including stigma and discrimination in healthcare settings. LGBTQ+-affirming SU treatment and related services remain limited. The purpose of this exploratory qualitative descriptive study was to characterise LGBTQ+ people’s experiences in SU services and recommendations for LGBTQ+- affirming care.

Methods

We...

While integrated services for mental health and substance use health have been studied for more than two decades no recent or comprehen­sive reviews exist — particularly with a peer research methodology — on how the people who use these services experience integration.

To address this need, this study explores

• how people with lived and living experience (PWLLE) define service integration,
• what gaps and demands exist in mental health and/or substance use health services,
• why participants do or do not support further service integration,
• which systemic bottlenecks prevent meaningful...

In North America, there's a serious problem with drug overdose deaths, mainly due to users encountering very strong and dangerous illegal opioids like fentanyl. Although various efforts have been made in Canada to address this issue, the death toll remains high. Since existing measures don't directly tackle the problem of toxic drug exposure, some places in Canada are trying a different approach called "safer drug supply." This involves providing users with prescribed, high-quality drugs to reduce the risk of overdose and death. While these measures have faced criticism and misconceptions...

At the 10th International Conference on Health and Hepatitis in Substance Users, held in Glasgow, Scotland, international policymakers gathered to discuss the global overdose crisis and the role that supervised consumption sites can play in helping end these needless and preventable deaths.

The policy brief

A new policy brief is now available that summarises the day’s discussions and provides a starting point for those wanting to know more about supervised consumption rooms and their impact.

It includes:

• Evidence of success
• Global case studies
• Evaluation models 
• Implementation...

In 2020, the Canadian Substance Use Costs and Harms (CSUCH) data reported that substance use resulted in a loss of $22.4 billion in productivity. This represents 45.6% of the overall cost and harms of substance use, which amounted to $49.1 billion in Canada for that year, as per the latest available data. The Canadian Centre on Substance Use and Addiction (CCSA) has recently published a resource titled "Cost of Substance Use on the Economic Productivity of Canadians – Findings at a Glance," which sheds light on the expenses and consequences linked to the decline in productivity. Some key...